Diabetes in Heart Failure: Prevalence and Impact on Outcome in the Population

Cited by (295)

Items 201–295 of 295

  1. Important Considerations for the Treatment of Patients with Diabetes Mellitus and Heart Failure from a Diabetologist’s Perspective: Lessons Learned from Cardiovascular Outcome Trials
    Chrysi C. Koliaki, Nicholas L. Katsilambros · 2019 · International Journal of Environmental Research and Public Health
  2. Inflammatory storm and metabolic disorders: unraveling heterogeneity in mortality risk for comorbid diabetes mellitus and heart failure via the C-reactive protein-triglyceride-glucose index
    Na Zhang, Lin Xie, Shuhua Zhang, Qun Wang, Hengcheng Lu, Zhiyu Xiong, Guobo Xie, Guotai Sheng, Hongyi Yang, Shiming He et al. · 2025 · Frontiers in Endocrinology
  3. Diabetes Does Not Affect Ventricular Repolarization and Sudden Cardiac Death Risk in Patients with Dilated Cardiomyopathy
    Bojan Vrtovec, Misa Fister, Gregor Poglajen, Vito Starc, François Haddad · 2009 · Pacing and Clinical Electrophysiology
  4. The effect of chronic heart failure and type 2 diabetes on insulin-stimulated endothelial function is similar and additive
    Britt Falskov, Hermann, Christian Rask‐Madsen, Major-Pedersen, Christiansen, Raunsø, Lars Køber, Christian Tobias Torp-Pedersen, Helena Domínguez · 2011 · Vascular Health and Risk Management
  5. Similar patterns of myocardial metabolism and perfusion in patients with type 2 diabetes and heart disease of ischaemic and non-ischaemic origin
    Stefano Masi, Riikka Läutamaki, Letizia Guiducci, Pietro Di Cecco, Cecilia Porciello, Silvia Pardini, Maria‐Aurora Morales, Vladyslav Chubuchny, Piero Antonio Salvadori, Michele Emdin et al. · 2012 · Diabetologia
  6. The impact of diabetes on heart failure: Opportunities for intervention
    Hadi N. Skouri, W.H. Wilson Tang · 2007 · Current Heart Failure Reports
  7. Heart Failure as a Consequence of Diabetic Cardiomyopathy
    Peter Noel Van Buren, Martin M. LeWinter · 2010 · Elsevier eBooks
  8. Prevalence and treatment of diabetes and pre-diabetes in a real-world heart failure population: a single-centre cross-sectional study
    Erik Håkansson, Mattias Brunström, Helena Norberg, Sara Själander, Krister Lindmark · 2022 · Open Heart
  9. Prevalent Diabetes Mellitus: Mortality and Management in Norwegian Heart Failure Outpatients
    Viera Stubnova, Ingrid Os, Morten Grundtvig, Bård Endre Waldum-Grevbo · 2016 · Cardiology
  10. Diabetes mellitus and congestive heart failure: the prevalence of congestive heart failure in patients with and without diabetes in Poland
    Waldemar Wierzba, Waldemar Karnafel, Andrzej M. Śliwczyński, Jarosław Pinkas, Mariusz Gujski · 2018 · Archives of Medical Science
  11. Assessing clinical and biomarker characteristics to optimize the benefits of sacubitril/valsartan in heart failure
    Sheldon E. Litwin, Cara Anne East · 2022 · Frontiers in Cardiovascular Medicine
  12. Islet transplantation attenuates cardiac fibrosis in diabetic rats through inhibition of TGF-β1/Smad3 pathway.
    Hongwei Wang, Yi-He Chen, Yanyan Chen, Wei Jian Huang, Xiandong Zhu, Fubiao Ni, Guo-Di Wu, Ziqiang Xu, Zhouqing Huang, Bicheng Chen et al. · 2018 · Europe PMC (PubMed Central)
  13. The clinical effects of levosimendan are not attenuated by sulfonylureas
    Matti Kivikko, Markku S. Nieminen, Piero Pollesello, Pasi Pohjanjousi, Wilson S. Colucci, John R. Teerlink, Alexandre Mebazaa · 2012 · Scandinavian Cardiovascular Journal
  14. Impact of Diabetes Mellitus on Survival in Patients Bridged to Transplantation with Left Ventricular Assist Devices in the United States
    Sadeer G Al-Kindi, Jassim M. S. Al Suwaidi, Amin Jayyousi, Guilherme H. Oliveira, Charbel Abi Khalil · 2018 · ASAIO Journal
  15. Left ventricular diastolic (dys)function in type 2 diabetes: time for a critical reappraisal
    Ariel A. Cohen, Stéphane Éderhy, Franck Boccara · 2007 · Diabetes & Metabolism
  16. Heart Failure Prevention
    Ziad A. Taimeh, Daniel A. Duprez, Daniel J. Garry · 2017 · Springer eBooks
  17. The limited clinical value of a specific diabetic cardiomyopathy
    Saula Vigili de Kreutzenberg, Angelo Avogaro · 2013 · Nutrition Metabolism and Cardiovascular Diseases
  18. Sex Differences in the Mortality Risk of Elderly Patients with Systolic Heart Failure in Taiwan.
    Tsung-Jui Wu, Gen‐Min Lin, Chin‐Sheng Lin, Pang‐Yen Liu, Kuan-Jen Su, Chia-Chang Lin, Tzu-Chiao Lin, Shu‐Meng Cheng, Shih-Hua Lin, Eiki Takimoto et al. · 2020 · PubMed Central
  19. Development of Prediction Model to Estimate the Risk of Heart Failure in Diabetes Mellitus
    Hongling Qu, Cuiyun Wu, Peijie Ye, Weibiao Lv · 2022 · Frontiers in Cardiovascular Medicine
  20. Identify of blood glucose metabolism regulation pathways and related proteins in the db/db mouse model through iTRAQ quantitative mass spectrometry
    Yilin Yue, Shanshan Dong, Zhihui Wu, Yongqing Dong, Qingpei Chen, Hong Wang, Chaowu Liu, Deguang Yang · 2025 · Acta Diabetologica
  21. A COMPREHENSIVE STUDY ON LITERATURE EVIDENCE, CLINICAL STUDIES AND PRACTICES OF HERBAL DRUGS FOR DIABETIC NEUROPATHY AND CARDIOMYOPATHY
    Arshiya Shamim, Hefazat Hussain Siddiqui, Tarique Mahmood, Paramdeep Bagga, Ranjan Kumar · 2017 · Asian Journal of Pharmaceutical and Clinical Research
  22. Prevalence and trends of type 2 diabetes mellitus and prediabetes among community-dwelling heart failure patients in the United States
    Yuta Ishikawa, Richard D. Lewis, Emma M. Laing, Alex Kojo Anderson, Donglan “Stacy” Zhang, Arshed Ali Quyyumi, Sandra Barker Dunbar, Rupal Trivedi, Elisabeth Lilian Pia Sattler · 2022 · Diabetes Research and Clinical Practice
  23. Short‐Term Survival in Elderly Patients Hospitalized for Heart Failure: The Role of Diabetes Mellitus and Newly Recognized Hyperglycemia
    Intissar Sleiman, Renzo Rozzini, Alessandro Giordano, Marco Trabucchi · 2009 · Journal of the American Geriatrics Society
  24. Difficulty Weaning Off Cardiopulmonary Bypass: Role of Diabetes-Associated Cardiomyopathy
    Thomas Nguyen Ahmed Zaky · 2013 · Journal of Diabetes & Metabolism
  25. Heart Failure as a Consequence of Ischemic Heart Disease
    James D. Flaherty, Robert O. Bonow, Mihai Gheorghiade · 2010 · Elsevier eBooks
  26. Diabetes mellitus und Herzinsuffizienz: Epidemiologie und Therapie
    Roman Pfister, Erland Erdmann · 2008 · Herz
  27. Heart Failure as a Consequence of Ischemic Heart Disease
    Gary Michael Felker, Douglas L. Mann, James D. Flaherty, Robert O. Bonow · 2020 · Elsevier eBooks
  28. Biomarkers of Myocardial Fibrosis in Diabetes, Echocardiography, and Magnetic Resonance Imaging
    Per Lav Madsen · 2022 · Biomarkers in disease
  29. Temporal trends on the prevalence of renal disease and outcomes among patients with diabetes mellitus hospitalized by heart failure: findings from INCAex
    José Carlos Arévalo‐Lorido, Juana Carretero‐Gómez, Alessia Rubini, Francisco Javier Félix-Redondo, Nicolás Roberto Robles Pérez-Monteoliva, Miriam Hernández González, Elena Vázquez Jarén, Bárbara Cancho Castellano, Reyes González-Fernández, Daniel J. Fernandez-Berges · 2024 · Expert Review of Endocrinology & Metabolism
  30. Diuretic Combination Therapy in Acute Heart Failure: An Updated Review
    Alessandro Villaschi, Marta Pellegrino, Gianluigi Condorelli, Mauro Chiarito · 2024 · Current Pharmaceutical Design
  31. Ischemic cardiomyopathy versus non-ischemic cardiomyopathy in diabetic patients: clinical characteristics, management, and long-term outcomes.
    Hanan B. Albackr, Turki B. Albacker, Fayez Elshaer, Nur Asfina, Fahad A. Al Subaie, Anhar A. Ullah, Ahmad Hayajneh, Osama Almogbel, Fakhr Alayoubi, Waleed Al Habeeb · 2022 · PubMed Central
  32. Associations of insulin resistance and type 2 diabetes to heart failure: Epidemiology, potential mechanisms, and clinical perspectives
    Erik Ingelsson · 2008 · Current Cardiovascular Risk Reports
  33. Common health problems management uncertainties in heart failure: a qualitative study.
    Paloma Gastelurrutia, Miguel Ángel Gastelurrutia, M J Faus, Antoni Bayés‐Genís · 2012 · PubMed
  34. Role of Pro-BNP in predicting outcome in acute heart failure patient presenting to a medical emergency: An observational study from North India
    Arjun Kumar Singhal, Gaurav Singh, SK Singh, Busi Karunanand, Sonu Kumari Agrawal · 2023 · Journal of Family Medicine and Primary Care
  35. Cardiac sympathetic innervation assessed with 123I-MIBG retains prognostic utility in diabetic patients with severe left ventricular dysfunction evaluated for primary prevention implantable cardioverter-defibrillator
    Pilar García-González, Óscar Fabregat‐Andrés, M. Cozar, Raúl Sánchez Jurado, Jordi Estornell-Erill, A. Valle-Muñoz, Aurelio Quesada, Rafael Payá-Serrano, Jose Ferrer-Rebolleda, Francisco Ridocci-Soriano · 2015 · Revista Española de Medicina Nuclear e Imagen Molecular
  36. DIABETES Y CORAZÓN
    Carlos Zavala U., Fernando Florenzano U. · 2015 · Revista Médica Clínica Las Condes
  37. An exploration of the connection between COVID-19 and cardiovascular disease (CVD) in European countries
    Niloufar Pourshir Sefidi, Peter Mooney · 2024 · Journal of Public Health
  38. Contemporary treatment strategies for Type 2 diabetes-related macrovascular disease
    Andrew MN Walker, Richard M. Cubbon, Mark T. Kearney · 2014 · Expert Review of Endocrinology & Metabolism
  39. Diabetic Cardiomyopathy: Distinct and Preventable Entity or Inevitable Consequence?
    Joel D. Schilling, Douglas L. Mann · 2014 · Current Cardiovascular Risk Reports
  40. Left ventricular systolic dysfunction in chronic kidney disease: from asymptomatic changes in geometry and function to overt heart failure
    Giovanni Cioffi, Luigi Tarantini, Pompilio Massimo Faggiano, Giovanni Pulignano, Giulia Russo, Andrea Di Lenarda · 2015 · Monaldi Archives for Chest Disease
  41. Riesgo de mortalidad en pacientes con diabetes mellitus tipo 2 hospitalizados por insuficiencia cardiaca aguda
    Pau Cerdà, Jonathan Franco, David Chivite, Francesç Formiga · 2016 · Revista Clínica Española
  42. Influence of Race in the Association of Diabetes and Heart Failure
    Hou-Tee Lu, R. bin Nordin, Aizai Azan Bin Abdul Rahim · 2017 · US Cardiology Review
  43. The Impact of SGLT2i Therapy on the Onset and Prognosis of Heart Failure in Patients with Type 2 Diabetes
    Bogdan Timar, Adina Braha, Lucica Grigorică, Laura Gaiţă, Romulus Zorin Timar · 2020 · Timişoara Medical Journal
  44. Type 2 diabetes mellitus and chronic heart failure: new treatment strategies
    I. Z. Bondarenko, Marina Gennad'evna Bubnova · 2021 · Cardiosomatics
  45. Effect of Glucagon-like Peptide-1 Receptor Agonist on Cardiac Structure and Function in Patients with Heart Failure: A Systematic Review and Meta-analysis
    Xinyu Zhang, Hongyuan Zhang · 2023 · International Journal of Drug Discovery and Pharmacology
  46. Stronger positive correlation of the left ventricular mass index and extracellular volume fraction with diastolic function in diabetic patients without myocardial infarction
    Hiroyuki Miura, Masahiro Koseki, Seiko Ide, Yasuhide Asaumi, Yoshiaki Morita, Yasutoshi Ohta, Katsunao Tanaka, Takeshi Okada, Takashi Omatsu, Soshiro Ogata et al. · 2024 · International Journal of Cardiology
  47. The Role of Left Ventricular Mass Index-adjusted Ejection Fraction in Early Detection of Diabetic Cardiomyopathy and its Association with Major Adverse Cardiovascular Events
    Pichakacheri Sureshkumar, Sidharth S Kumar, Rajesh Gopalan Nair, P. K. Asokan · 2025 · Journal of Indian College of Cardiology
  48. Dipeptidyl Peptidase-4 Inhibitors and Heart Failure: Friends or Foes?
    Matteo Monami, Edoardo Mannucci · 2015 · Current Cardiovascular Risk Reports
  49. review on epidemiology, biochemical characteristics, treatment suggestions, and continued studies on diabetes and cardiovascular disease
    Rajni Yadav · 2022 · International Journal of Health Sciences
  50. The Impact of Antithrombotic Therapy in Patients with De-compensated Heart Failure and Iron
    Ion Alexandru Cristian, Liviu Ionuț Șerbănoiu, Ștefan Busnatu, Valentin Chioncel, Cătălina Liliana Andrei · 2022 · Balneo and PRM Research Journal
  51. Ischaemic Heart Disease : Early Recognition and Risk Disparities
    Ingrid E.M. Bank · 2017 · Utrecht University Repository (Utrecht University)
  52. The 6th Annual World Congress on the Insulin Resistance Syndrome
    Zachary T. Bloomgarden · 2009 · Diabetes Care
  53. SURVIVAL AND INFLAMMATION IN PATIENTS WITH HEART FAILURE: THE IMPACT OF OVERWEIGHT, OBESITY, DIABETES AND FRUIT AND VEGETABLE CONSUMPTION
    Heather Payne-Emerson · 2010
  54. Seguimiento farmacoterapéutico y de la composición corporal en pacientes con insuficiencia cardiaca
    Paloma Gastelurrutia · 2012 · Institutional Repository of the University of Granada (University of Granada)
  55. Insulintherapie bei Patienten mit Herzerkrankungen
    Andreas Pfützner, Thomas M. Forst · 2011 · Der Diabetologe
  56. Novel mechanistic insights into the role of advanced glycation end products in the development of diabetic cardiomyopathy
    Zeinab Hegab · 2012 · Research Explorer (The University of Manchester)
  57. Update on heart failure
    Benjamin R. Szwejkowski, Sushma Rekhraj, Douglas H.J. Elder, Allan D. Struthers · 2011 · The British Journal of Diabetes
  58. Insulin Resistance and Progression of Heart Failure in the Older Adult
    Shashank S. Sinha, Richard P. Shannon · 2011 · Aging Health
  59. Does renal function influence the prognostic impact of type 2 diabetes mellitus in patients with chronic heart failure and left ventricular dysfunction?
    Giulia Russo, Giovanni Cioffi, Luigi Tarantini, Antonella Cherubini, Giorgio Faganello, Carmine Mazzone, Giulia Barbati, Riccardo Candido, Pompilio Massimo Faggiano, Andrea Di Lenarda · 2014 · IJC Metabolic & Endocrine
  60. Difficulty Weaning Off Cardiopulmonary Bypass: Role of Diabetes-
    Thomas Nguyen, Ahmed Zaky · 2013
  61. Disease Prevention in Heart Failure
    Viorel G. Florea, Jay N. Cohn · 2010 · Elsevier eBooks
  62. Vincent M. van DeursenKevin DammanPeter van der Meer • Peter J. WijkstraGert-Jan LuijckxAndre van BeekDirk J. van Veldhuisen •
    Adriaan A. Voors · 2014
  63. Optimal glycemic control improves outcomes of chronic heart failure
    2007 · The Internet Journal of Cardiovascular Research
  64. oxide synthase gene is associated with insulin resistance in patients with ischemic or non ischemic cardiomyopathy
    Cecilia Vecoli, Maria Grazia Andreassi, Riccardo Liga, Maria Giovanna Colombo, Michele Alessandro Coceani, Clara Carpeggiani, Danilo Neglia · 2012
  65. New options in the treatment of patients with diabetes and heart failure. Generalized Russian experience
    Ametov As, Elena Valer'evna Doskina · 2016 · Meditsinskiy sovet = Medical Council
  66. The epidemiology of sudden cardiac death in Western Australia
    Feng, Jiali · 2016 · UWA Profiles and Research Repository (University of Western Australia)
  67. Exploring heart failure events in contemporary cardiovascular outcomes trials in type 2 diabetes mellitus
    Shilpa Vijayakumar, Muthiah Vaduganathan, Javed Butler · 2018 · Expert Review of Cardiovascular Therapy
  68. Comparative study of Left Ventricular Function by Echocardiography in Type 2 Diabetes Mellitus Patients With and Without Retinopathy
    K. Bhargavi · 2013
  69. Chronic Heart Failure: An Epidemiological Study Of Impaired Oxidative Stress
    Jenny Bjerre · 2018 · Clinical Cardiology and Cardiovascular Interventions
  70. The Epidemic of Diabetes and its Negative Impact on Other Diseases
    Waldemar Wierzba, Witold Laskowski, Waldemar Karnafel, Jakub Owoc · 2017 · Przedsiebiorczosc i Zarzadzanie
  71. Der Einfluss einer prädiabetischen Stoffwechsellage und eines manifesten Diabetes mellitus Typ II auf die Entwicklung einer Herzinsuffizienz im 10-Jahres-Verlauf
    Fehr, Sarah · 2020
  72. Patterns of heart failure patients – Data from a single East-European centre
    Robert Adrian Dumbravă, Maria Andrada Jiga, Dragos-Gabriel Iancu, Liviu Cristescu, Radu Tătar, Andreea VARGA · 2020 · Romanian Journal of Medical Practice
  73. Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Heart Failure
    Lourdes V. Cross, Aya Zbedah, Brooke Kearney · 2021 · ADCES in Practice
  74. Glycemic Control is Associated with Heart Failure with Recovered Ejection Fraction in Diabetic Patients
    Chen Die Yang, Muladili Aihemaiti, Feng Hua Ding, ZHEN KUN YANG, Jian Hu, Wei Feng Shen, Lin Lü, Ruiyan Zhang, Xiao Qun Wang · 2021 · Research Square
  75. Current World Literature
    2007 · Current Opinion in Endocrinology Diabetes and Obesity
  76. Cardiac sympathetic innervation assessed with 123I-MIBG retains prognostic utility in diabetic patients with severe left ventricular dysfunction evaluated for primary prevention implantable cardioverter-defibrillator
    Pilar García-González, Óscar Fabregat‐Andrés, M. Cozar, Raúl Sánchez Jurado, Jordi Estornell-Erill, A. Valle-Muñoz, Aurelio Quesada-Dorador, Rafael Payá-Serrano, Jose Ferrer-Rebolleda, Francisco Ridocci-Soriano · 2016 · Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
  77. Spettroscopia RM
    Gianluca Perseghin, Francesco DE COBELLI · 2010 · Springer eBooks
  78. Biomarkers of Myocardial Fibrosis in Diabetes, Echocardiography, and Magnetic Resonance Imaging
    Per Lav Madsen · 2022 · Biomarkers in disease
  79. Nursing care for people with concurrent heart failure and diabetes: A scoping review
    Yusuke Yamazaki, Sumie Kuroda, Misaki Sawaoka · 2023 · Journal of International Nursing Research
  80. The role of epigenetics in cardiovascular disease
    Floriana Maria Farina, Ignacio Fernando Hall, Christina Pagiatakis, Montserrat Climent, Leonardo Elia · 2023 · Elsevier eBooks
  81. Epigenetic drugs: a new frontier in the treatment of heart failure
    К. А. Айтбаев, Ilkhom T. Murkamilov, Муркамилова Жамила Абдилалимовна, Victor V. Fomin, Indira Kudaibergenova, T. F. Yusupova, Furkat A. Yusupov · 2023 · Eurasian heart journal
  82. The two different profiles in heart failure with preserved ejection fraction and type 2 diabetes mellitus: ischemic and diabetic
    José Carlos Arévalo‐Lorido, Juana Carretero‐Gómez, Alicia Conde Martel, Óscar Aramburu Bodas, Joan Carles Trullàs, Francisco Javier Carrasco-Sánchez, Luís Manzano, J. González, Carmen Moreno García, Jesús Casado et al. · 2024 · Current Medical Research and Opinion
  83. Expanding Indications for the Sodium-Cotransporter Glucose 2 Inhibitors Application in Type 2 Diabetes Mellitus
    Tatiana V. Mokhort · 2024 · Рецепт
  84. Risk management of patients with multiple CVDs: what are the best practices?
    Amer Harky, Roshni S.K. Patel, Maya Yien, Abdullah Khaled, Dang H. Nguyen, Sakshi Roy, Mohamed Zeinah · 2024 · Expert Review of Cardiovascular Therapy
  85. Does Your Cataract Surgeon Know You Were Admitted for Heart Failure Last Week?
    Michael J. Curtis, Nathaen S. Weitzel, Miklos David Kertai · 2025 · Perioperative Medicine
  86. Incidence and determinants of left ventricular ejection fraction (LVEF) recovery in heart failure with reduced ejection fraction (HFrEF) of non-ischemic aetiology; a hospital-based prospective longitudinal registry study
    Sanjeev Kumar, Prakash Chand Negi, Sanjeev Asotra, Jitender Kumar, Rajeev Merwah, Rajesh Sharma, Ritesh Kumar, Vinay Bhardwaj, Preetam Singh Thakur · 2025 · Indian Heart Journal
  87. Echocardiographic study of myocardial work in elderly type 2 diabetes mellitus patients with microalbuminuria
    Heling Wen, Hui Li, Min Hong, Wenjie Tian, Lei Peng, Yuyan Chen · 2025 · BMC Geriatrics
  88. Additional file 1 of Monocyte to high-density lipoprotein cholesterol ratio predicts poor outcomes in ischaemic heart failure patients combined with diabetes: a retrospective study
    Q Y Li, Xiaolong Lin, Xiaowen Bo, Li, Fanqi, Chen, Siyuan, Miao, Xuguang, Zhao, Donghui, Jinghua Liu, Qian Fan · 2023 · Figshare
  89. Additional file 1 of The novel inflammatory biomarker GlycA and triglyceride-rich lipoproteins are associated with the presence of subclinical myocardial dysfunction in subjects with type 1 diabetes mellitus
    Carlos Puig-Jové, Josep Julve, Esmeralda Castelblanco, María Teresa Julián, Amigó, Núria, Andersen, Henrik U, Ahluwalia, Tarunveer S, Rossing, Peter, Dı́dac Mauricio, Jensen, Magnus T et al. · 2022 · Figshare
  90. Dipeptidyl Peptidase‐4 Inhibitors Associated Heart Failure Events in Adult Patients With Type‐2 Diabetes Mellitus Treated With Dipeptidyl Peptidase‐4 Inhibitors: A Systematic Review and Meta‐Analysis
    Shishir Nepal, Shiva Prasad Nepal · 2026 · Endocrinology Diabetes & Metabolism
  91. The Liver-Heart Axis: A Narrative Review of Clinical Implications of the MASLD Redefinition for Internists
    Hassan A. Abdou, Saied A. Omar · 2026 · ASIDE Gastroenterology
  92. Combined effect of educational attainment and diabetes on 1-year all-cause mortality in heart failure patients: findings from the National Heart Failure Registry, India
    Panniyammakal Jeemon, Sunu C Thomas, Ajay Bahl, Ambuj Roy, Animesh Mishra, Jayesh Prajapati, Manjunath Cholenahally Nanjappa, Rishi Sethi, Santanu Guha, Satheesh Santhosh et al. · 2026 · Open Heart
  93. The association of high-sensitivity C-reactive protein levels and their changes with heart failure in Chinese diabetes patients
    Peipei Liu, Shuohua Chen, Man Li, Yanxiu Wang, Youxin Wang · 2026 · Journal of Endocrinological Investigation
  94. Characteristics and Care Practices in People Hospitalized for Heart Failure With Coexisting Diabetes
    Yusuke Yamazaki, Sumie Kuroda, Shizue Kobayashi, Kageyama Saki · 2026 · The Journal of Cardiovascular Nursing
  95. Função cardíaca em cães com Diabetes Mellitus
    Fabrício Andrade Marinho · 2013 · Americanae (AECID Library)